ABOUT THE PRODUCT
EarlyTect BCD is a urine-based test designed for the early detection of bladder cancer. It utilizes our patented LTE-qMSP technology to identify methylated DNA biomarkers indicative of bladder cancer, offering a convenient and accurate screening option.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Promis Diagnostics
Urinalysis
Biotechnology
N/A
Promis Diagnostics
United States (US)